{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:44:02Z","timestamp":1769607842365,"version":"3.49.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T00:00:00Z","timestamp":1491350400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s40264-017-0525-2","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T11:55:35Z","timestamp":1491393335000},"page":"583-596","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Drospirenone-Containing Oral Contraceptive Pills and the Risk of Venous Thromboembolism: An Assessment of Risk in First-Time Users and Restarters"],"prefix":"10.1007","volume":"40","author":[{"given":"Natasha","family":"Lariv\u00e9e","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy","family":"Suissa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janie","family":"Coulombe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky","family":"Tagalakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristian B.","family":"Filion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,5]]},"reference":[{"issue":"5","key":"525_CR1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.contraception.2006.12.019","volume":"75","author":"JC Dinger","year":"2007","unstructured":"Dinger JC, Heinemann LA, Kuhl-Habich D. The safety of a drospirenone-containing oral contraceptive: final results from the European Active Surveillance Study on oral contraceptives based on 142,475 women-years of observation. Contraception. 2007;75(5):344\u201354.","journal-title":"Contraception"},{"issue":"4","key":"525_CR2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2014.01.023","volume":"89","author":"J Dinger","year":"2014","unstructured":"Dinger J, Bardenheuer K, Heinemann K. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives. Contraception. 2014;89(4):253\u201363.","journal-title":"Contraception"},{"issue":"2","key":"525_CR3","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00404-013-2983-9","volume":"289","author":"M Ziller","year":"2014","unstructured":"Ziller M, Ziller V, Haas G, Rex J, Kostev K. Risk of venous thrombosis in users of hormonal contraceptives in German gynaecological practices: a patient database analysis. Arch Gynecol Obstet. 2014;289(2):413\u20139.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"525_CR4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/01.AOG.0000279448.62221.a8","volume":"110","author":"JD Seeger","year":"2007","unstructured":"Seeger JD, Loughlin J, Eng PM, Clifford CR, Cutone J, Walker AM. Risk of thromboembolism in women taking ethinylestradiol\/drospirenone and other oral contraceptives. Obstet Gynecol. 2007;110(3):587\u201393.","journal-title":"Obstet Gynecol"},{"key":"525_CR5","doi-asserted-by":"crossref","first-page":"b2890","DOI":"10.1136\/bmj.b2890","volume":"339","author":"O Lidegaard","year":"2009","unstructured":"Lidegaard O, Lokkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339:b2890.","journal-title":"BMJ"},{"key":"525_CR6","unstructured":"Joint Meeting of the Advisory Committee for Reproductive Health Drugs and the Drug Safety and Risk Management Advisory Committee. 2011 [cited; Available from: http:\/\/www.fda.gov\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/ReproductiveHealthDrugsAdvisoryCommittee\/ucm282460.htm ."},{"issue":"18","key":"525_CR7","doi-asserted-by":"crossref","first-page":"E1319","DOI":"10.1503\/cmaj.110463","volume":"183","author":"N Gronich","year":"2011","unstructured":"Gronich N, Lavi I, Rennert G. Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study. CMAJ Canadian Medical Association Journal. 2011;183(18):E1319\u201325.","journal-title":"CMAJ Canadian Medical Association Journal."},{"issue":"5","key":"525_CR8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.contraception.2016.01.012","volume":"93","author":"J Dinger","year":"2016","unstructured":"Dinger J, Mohner S, Heinemann K. Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives. Contraception. 2016;93(5):378\u201385.","journal-title":"Contraception."},{"key":"525_CR9","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","volume":"343","author":"O Lidegaard","year":"2011","unstructured":"Lidegaard O, Nielsen LH, Skovlund CW, Skjeldestad FE, Lokkegaard E. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: danish cohort study, 2001\u20139. BMJ. 2011;343:d6423.","journal-title":"BMJ"},{"issue":"2","key":"525_CR10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jfprhc-2012-100297","volume":"38","author":"M Leppee","year":"2012","unstructured":"Leppee M, Culig J. Difference between drospirenone-containing oral contraceptives and other oral contraceptives related to risk of venous thromboembolism. J Family Plan Reprod Health Care. 2012;38(2):137\u20138.","journal-title":"J Family Plan Reprod Health Care"},{"issue":"1","key":"525_CR11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","volume":"87","author":"S Sidney","year":"2013","unstructured":"Sidney S, Cheetham TC, Connell FA, Ouellet-Hellstrom R, Graham DJ, Davis D, et al. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users. Contraception. 2013;87(1):93\u2013100.","journal-title":"Contraception"},{"key":"525_CR12","doi-asserted-by":"crossref","first-page":"d2151","DOI":"10.1136\/bmj.d2151","volume":"342","author":"SS Jick","year":"2011","unstructured":"Jick SS, Hernandez RK. Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case\u2013control study using United States claims data. BMJ. 2011;342:d2151.","journal-title":"BMJ"},{"key":"525_CR13","first-page":"8","volume":"339","author":"AV Vlieg","year":"2009","unstructured":"Vlieg AV, Helmerhorst FM, Vandenbroucke JP, Doggen CJM, Rosendaal FR. The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. BMJ Br Med J. 2009;339:8.","journal-title":"BMJ Br Med J"},{"issue":"3","key":"525_CR14","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/AOG.0000000000000411","volume":"124","author":"A Bergendal","year":"2014","unstructured":"Bergendal A, Persson I, Odeberg J, Sundstrom A, Holmstrom M, Schulman S, et al. Association of venous thromboembolism with hormonal contraception and thrombophilic genotypes. Obstet Gynecol. 2014;124(3):600\u20139.","journal-title":"Obstet Gynecol"},{"key":"525_CR15","doi-asserted-by":"crossref","first-page":"d2139","DOI":"10.1136\/bmj.d2139","volume":"342","author":"L Parkin","year":"2011","unstructured":"Parkin L, Sharples K, Hernandez RK, Jick SS. Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database. BMJ. 2011;342:d2139.","journal-title":"BMJ"},{"key":"525_CR16","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","volume":"350","author":"Y Vinogradova","year":"2015","unstructured":"Vinogradova Y, Coupland C, Hippisley-Cox J. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases. BMJ. 2015;350:h2135.","journal-title":"BMJ"},{"issue":"3","key":"525_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1783\/147118910791749416","volume":"36","author":"J Dinger","year":"2010","unstructured":"Dinger J, Assmann A, Mohner S, Minh TD. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study. J Family Plan Reprod Health Care. 2010;36(3):123\u20139.","journal-title":"J Family Plan Reprod Health Care"},{"issue":"5","key":"525_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/2042098614548857","volume":"5","author":"J Brynhildsen","year":"2014","unstructured":"Brynhildsen J. Combined hormonal contraceptives: prescribing patterns, compliance, and benefits versus risks. Therap Adv Drug Safe. 2014;5(5):201\u201313.","journal-title":"Therap Adv Drug Safe"},{"issue":"6","key":"525_CR19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jclinepi.2009.01.006","volume":"62","author":"S Suissa","year":"2009","unstructured":"Suissa S. The Transnational study of oral contraceptive cardiovascular safety: history and science. J Clin Epidemiol. 2009;62(6):588\u201393.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"525_CR20","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/humrep\/15.4.817","volume":"15","author":"S Suissa","year":"2000","unstructured":"Suissa S, Spitzer WO, Rainville B, Cusson J, Lewis M, Heinemann L. Recurrent use of newer oral contraceptives and the risk of venous thromboembolism. Hum Reprod. 2000;15(4):817\u201321.","journal-title":"Hum Reprod"},{"issue":"3","key":"525_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0010-7824(97)00119-4","volume":"56","author":"S Suissa","year":"1997","unstructured":"Suissa S, Blais L, Spitzer WO, Cusson J, Lewis M, Heinemann L. First-time use of newer oral contraceptives and the risk of venous thromboembolism. Contraception. 1997;56(3):141\u20136.","journal-title":"Contraception"},{"issue":"6","key":"525_CR22","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/humrep\/14.6.1493","volume":"14","author":"MA Lewis","year":"1999","unstructured":"Lewis MA, MacRae KD, Kuhl-Habichl D, Bruppacher R, Heinemann LA, Spitzer WO. The differential risk of oral contraceptives: the impact of full exposure history. Hum Reprod. 1999;14(6):1493\u20139.","journal-title":"Hum Reprod"},{"issue":"3","key":"525_CR23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","volume":"44","author":"E Herrett","year":"2015","unstructured":"Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, et al. Data resource profile: clinical practice research datalink (CPRD). Int J Epidemiol. 2015;44(3):827\u201336.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"525_CR24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","volume":"69","author":"E Herrett","year":"2010","unstructured":"Herrett E, Thomas SL, Schoonen WM, Smeeth L, Hall AJ. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol. 2010;69(1):4\u201314.","journal-title":"Br J Clin Pharmacol"},{"issue":"572","key":"525_CR25","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.3399\/bjgp10X483562","volume":"60","author":"NF Khan","year":"2010","unstructured":"Khan NF, Harrison SE, Rose PW. Validity of diagnostic coding within the General Practice Research Database: a systematic review. Br J Gen Pract. 2010;60(572):e128\u201336.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"525_CR26","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/toxsci\/kfr242","volume":"125","author":"KD Chadwick","year":"2012","unstructured":"Chadwick KD, Burkman RT, Tornesi BM, Mahadevan B. Fifty years of \u201cthe Pill\u201d: risk reduction and discovery of benefits beyond contraception, reflections, and forecast. Toxicol Sci. 2012;125(1):2\u20139.","journal-title":"Toxicol Sci"},{"issue":"2","key":"525_CR27","first-page":"120","volume":"9","author":"E Previtali","year":"2011","unstructured":"Previtali E, Bucciarelli P, Passamonti SM, Martinelli I. Risk factors for venous and arterial thrombosis. Blood Transfus. 2011;9(2):120\u201338.","journal-title":"Blood Transfus"},{"issue":"6","key":"525_CR28","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1365-2125.2000.00199.x","volume":"49","author":"R Lawrenson","year":"2000","unstructured":"Lawrenson R, Todd JC, Leydon GM, Williams TJ, Farmer RD. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol. 2000;49(6):591\u20136.","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"525_CR29","doi-asserted-by":"crossref","first-page":"e70310","DOI":"10.1371\/journal.pone.0070310","volume":"8","author":"A Abdul Sultan","year":"2013","unstructured":"Abdul Sultan A, Tata LJ, Grainge MJ, West J. The incidence of first venous thromboembolism in and around pregnancy using linked primary and secondary care data: a population based cohort study from England and comparative meta-analysis. PLoS One. 2013;8(7):e70310.","journal-title":"PLoS One"},{"issue":"1","key":"525_CR30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jfprhc-2011-100260","volume":"38","author":"J Dinger","year":"2012","unstructured":"Dinger J, Shapiro S. Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets. J Family Plan Reprod Health Care. 2012;38(1):2\u20136.","journal-title":"J Family Plan Reprod Health Care"},{"issue":"23","key":"525_CR31","first-page":"I9","volume":"107","author":"FA Anderson","year":"2003","unstructured":"Anderson FA, Spencer FA. Four topics in venous thromboembolism: risk factors for venous thromboembolism. Circulation. 2003;107(23):I9.","journal-title":"Circulation"},{"key":"525_CR32","doi-asserted-by":"crossref","unstructured":"Reid R, Society of O, Gynaecologists of C. SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update. J Obst Gynaecol Can: JOGC 2010;32(12):1192\u2013204.","DOI":"10.1016\/S1701-2163(16)34746-6"},{"issue":"1","key":"525_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2010.01.057","volume":"56","author":"SZ Goldhaber","year":"2010","unstructured":"Goldhaber SZ. Risk factors for venous thromboembolism. J Am Coll Cardiol. 2010;56(1):1\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"525_CR34","doi-asserted-by":"crossref","unstructured":"Vinogradova Y, Coupland C, Hippisley-Cox J. Exposure to combined oral contraceptives and risk of venous thromboembolism: a protocol for nested case-control studies using the QResearch and the CPRD databases. BMJ Open 2014;4(4).","DOI":"10.1136\/bmjopen-2013-004499"},{"issue":"4","key":"525_CR35","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","volume":"20","author":"S Schneeweiss","year":"2009","unstructured":"Schneeweiss S, Rassen JA, Glynn RJ, Avorn J, Mogun H, Brookhart MA. High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology. 2009;20(4):512\u201322.","journal-title":"Epidemiology"},{"issue":"1","key":"525_CR36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1783\/147118910790291037","volume":"36","author":"S Shapiro","year":"2010","unstructured":"Shapiro S, Dinger J. Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies. J Family Plan Reprod Health Care. 2010;36(1):33\u20138.","journal-title":"J Family Plan Reprod Health Care"},{"key":"525_CR37","doi-asserted-by":"crossref","unstructured":"Rashed AN, Hsia Y, Wilton L, Ziller M, Kostev K, Tomlin S. Trends and patterns of hormonal contraceptive prescribing for adolescents in primary care in the UK. J Family Plan Reprod Health Care 2015;41(3):216\u201322.","DOI":"10.1136\/jfprhc-2013-100724"},{"key":"525_CR38","unstructured":"Teenagers: sexual health and behaviour factsheet. Available from: http:\/\/www.fpa.org.uk\/factsheets\/teenagers-sexual-health-behaviour . Cited 6 March 2016."},{"key":"525_CR39","unstructured":"NHS Contraceptive Services, England \u2013 2012\u20132013, Community contraceptive clinics [NS]. 2013; Available from: http:\/\/www.hscic.gov.uk\/catalogue\/PUB12548 . Cited 13 April 2016."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-017-0525-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0525-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-017-0525-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T13:21:19Z","timestamp":1568985679000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-017-0525-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,5]]},"references-count":39,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["525"],"URL":"https:\/\/doi.org\/10.1007\/s40264-017-0525-2","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,5]]}}}